Discover
EPRX
Eupraxia Pharmaceuticals Inc.
8.58
2 x 6.14
2 x 10.88
bid
ask
+
0.20
2.39%
2 @ 04:00 PM
8.58 +0.00 (0.00%)
| Ytd | 13.64% | |
| 1y | 42.05% |
8.37
day range
8.71
5.16
52 week range
9.32
| Open | 8.37 | Prev Close | 8.38 | Low | 8.37 | High | 8.71 | Mkt Cap | 566.91M |
| Vol | 555.04K | Avg Vol | 427.18K | EPS | -1.02 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.23 | Short Ratio | 27.74 | Inst. Own | 12.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 6.95 | 200-d Avg | 7.22 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 18.10M | ||
| Research and Development Expense | 12.81M | ||
| Selling, General and Administrative Expense | 5.30M | ||
| Operating Income | -18.10M | ||
| Income Tax Expense | 30.38K | ||
| Net Income | -14.49M | ||
| Net Income Common Stock | -14.49M | ||
| Net Income Common Stock (USD) | -14.49M | ||
| Consolidated Income | -14.49M | ||
| Net Income to Non-Controlling Interests | 6.48K | ||
| Earnings per Basic Share | -0.23 | ||
| Earnings per Basic Share (USD) | -0.23 | ||
| Earnings per Diluted Share | -0.23 | ||
| Earning Before Interest & Taxes (EBIT) | -14.46M | ||
| Earning Before Interest & Taxes (USD) | -14.46M | ||
| Weighted Average Shares | 66.22M | ||
| Weighted Average Shares Diluted | 66.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 52.43M | ||
| Cash and Equivalents (USD) | 52.43M | ||
| Investments | 81.23M | ||
| Investments Current | 81.23M | ||
| Trade and Non-Trade Receivables | 688.22K | ||
| Current Assets | 136.80M | ||
| Property, Plant & Equipment Net | 3.05M | ||
| Total Assets | 139.91M | ||
| Debt Current | 159.88K | ||
| Total Debt | 1.84M | ||
| Current Liabilities | 8.55M | ||
| Debt Non-Current | 1.68M | ||
| Total Liabilities | 10.23M | ||
| Accumulated Retained Earnings (Deficit) | -196.72M | ||
| Accumulated Other Comprehensive Income | -7.01M | ||
| Shareholders Equity | 131.28M | ||
| Shareholders Equity (USD) | 131.28M | ||
| Assets Non-Current | 3.10M | ||
| Total Debt (USD) | 1.84M | ||
| Liabilities Non-Current | 1.68M | ||
| Trade and Non-Trade Payables | 8.39M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 7.48M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.79M | ||
| Capital Expenditure | -173.09K | ||
| Issuance (Purchase) of Equity Shares | 7.48M | ||
| Net Cash Flow from Investing | -173.09K | ||
| Net Cash Flow from Operations | -13.09M | ||
| Effect of Exchange Rate Changes on Cash | -283.99K | ||
| Share Based Compensation | 3.03M | ||